We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current MRCK34 market cap is 208.58B. The company's latest EPS is USD 0.1440 and P/E is 890.69.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 14.96B | 13.83B | 14.49B | 15.04B | 15.96B |
| Operating Income | 4.01B | 3.44B | 3.74B | -5.17B | 5.75B |
| Net Income | 3.25B | 3.02B | 2.82B | -5.98B | 4.75B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 46.84B | 47.99B | 48.7B | 59.28B | 60.12B |
| Operating Income | 11.6B | 7.91B | 12.54B | 17.95B | 2.36B |
| Net Income | 9.71B | 7.07B | 13.05B | 14.52B | 365M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 107.08B | 109.16B | 107.8B | 104.47B | 106.73B |
| Total Liabilities | 62.56B | 63.1B | 60.89B | 65.73B | 65.43B |
| Total Equity | 44.52B | 46.06B | 46.91B | 38.74B | 41.3B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 84.4B | 91.59B | 105.69B | 109.16B | 106.68B |
| Total Liabilities | 58.4B | 66.18B | 67.44B | 63.1B | 69.04B |
| Total Equity | 26B | 25.4B | 38.26B | 46.06B | 37.64B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 14.67B | 19.1B | 1.34B | 5.04B | 12.76B |
| Investing | -3.21B | -4.96B | -2.36B | -13.8B | -14.14B |
| Financing | -7.57B | -9.12B | -2.05B | 1.7B | -2.57B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 13.44B | 10.25B | 14.11B | 19.1B | 13.01B |
| Investing | -2.63B | -9.44B | -16.56B | -4.96B | -14.08B |
| Financing | -8.86B | -2.83B | 2.59B | -9.12B | -4.81B |
| Market Cap | 208.58B |
| Price to Earnings Ratio | 890.69 |
| Price to Sales Ratio | 5.41 |
| Price to Cash Ratio | 47.51 |
| Price to Book Ratio | 8.64 |
| Dividend Yield | - |
| Shares Outstanding | 2.53B |
| Average Volume (1 week) | 5.84k |
| Average Volume (1 Month) | 2.97k |
| 52 Week Change | 12.46% |
| 52 Week High | 85.35 |
| 52 Week Low | 61.00 |
| Spread (Intraday) | 5.78 (6.74%) |
| Company Name | Merck Drn Ed Mb |
| Address |
820 bear tavern road west trenton, new jersey 08628 1021 |
| Website | https://www.merck.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
